Evaluating the Results of Clinical Trials in Inflammatory Bowel Disease: Can We Reconcile the Controversies?

Evaluating the Results of Clinical Trials in Inflammatory Bowel Disease: Can We Reconcile the Controversies?

Bibliographic Details
Main Authors:	Gary R May, Eldon A Shaffer
Format:	Article
Language:	English
Published:	Hindawi Limited 1994-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1994/623480

Similar Items

News and controversy in inflammatory bowel disease treatment
by: Giulia Straforini, et al.
Published: (2013-04-01)

Can We Predict the Toxicity and Response to Thiopurines in Inflammatory Bowel Diseases?
by: Raphael P. Luber, et al.
Published: (2019-11-01)

Controversies Regarding the Role of Dairy Products in Inflammatory Bowel Disease
by: Seymour Mishkin
Published: (1994-01-01)

How Can We Do Transition Successfully from Pediatric to Adult Clinics in Inflammatory Bowel Disease?
by: Mi Jin Kim, et al.
Published: (2021-05-01)

What's New and Controversial? A Critical Critique! - Inflammatory Bowel Disease
by: Desmond Leddin
Published: (1990-01-01)

Dietary Strategies for Maintenance of Clinical Remission in Inflammatory Bowel Diseases: Are We There Yet?
by: Konstantinos Gkikas, et al.
Published: (2020-07-01)

Assessing Outcome in Randomized Clinical Trials: Inflammatory Bowel Disease
by: E Jan Irvine
Published: (1993-01-01)

The Placebo and Nocebo Responses in Clinical Trials in Inflammatory Bowel Diseases
by: Paul Enck, et al.
Published: (2021-03-01)

Membrane progestin receptors: beyond the controversy, can we move forward?
by: Salhi Amel, et al.
Published: (2010-05-01)

Information Needs and Concerns of Patients with Inflammatory Bowel Disease: What Can We Learn from Participants in a Bilingual Clinical Cohort?
by: Valérie Pittet, et al.
Published: (2016-01-01)

Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?
by: Asaf Levartovsky, et al.
Published: (2020-08-01)

Whatever we should know about inflammatory bowel diseases
by: Asemi, S
Published: (1998-05-01)

Can morality and ethical be reconciled?
by: Giusti, Miguel
Published: (2013)

Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases
by: Atsunori Tsuchiya, et al.
Published: (2017-07-01)

Can microscopic ileitis in patients with clinically suspected inflammatory bowel disease predict the future?
by: Fadi Abu Baker, et al.
Published: (2020-03-01)

Insurance Rating of Patients with Inflammatory Bowel Disease: Report of a Conference on Morbidity and Mortality
by: Ivan T Beck, et al.
Published: (1994-01-01)

Can we reconcile individualisation with relational ‘personhood: a case study from the Early Neolithic
by: Chapman John, et al.
Published: (2011-12-01)

Can We Distinguish between Inflammatory and Neuropathic Pain?
by: Gary J Bennett
Published: (2006-01-01)

Adaptive Designs: Lessons for Inflammatory Bowel Disease Trials
by: Ferdinando D'Amico, et al.
Published: (2020-07-01)

Clinical Diagnosis: When Is It Not Inflammatory Bowel Disease?
by: CN Williams
Published: (1990-01-01)

Inflammatory bowel disease: clinical aspects and treatments
by: Fakhoury M, et al.
Published: (2014-06-01)

Clinical Quality Indicators in Inflammatory Bowel Disease
by: Subrata Ghosh
Published: (2014-01-01)

Clinical value of antibodies in inflammatory bowel diseases
by: E. N. Aleksandrova, et al.
Published: (2021-02-01)

Can we reconcile differences in estimates of carbon fluxes from land-use change and forestry for the 1990s?
by: A. Ito, et al.
Published: (2008-06-01)

Asian Physician’s Perspectives on Biosimilars in Inflammatory Bowel Disease: Are We Ready to Use?
by: Soo-Young Na
Published: (2019-12-01)

Iron Deficiency Anemia in Inflammatory Bowel Disease: What Do We Know?
by: Tamás Resál, et al.
Published: (2021-07-01)

Sometimes, when we talk about Damaged Buildings-it can be controversial
by: Awwad Talal, et al.
Published: (2019-01-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Special Problems Associated with Surgical Trials in Inflammatory Bowel Disease
by: Robin S McLeod
Published: (1995-01-01)

Clinical Trials in Portugal: How Can we Improve?
by: Marta Carvalho, et al.
Published: (2021-02-01)

Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results
by: Rebecca Sagar, et al.
Published: (2021-04-01)

Can Human Rights be Reconciled with State Sovereignty?
by: Abdullah Kadir, et al.
Published: (2017-10-01)

INFLAMMATORY BOWEL DISEASE
by: I Gusti Ayu Mahaprani Danastri, et al.
Published: (2013-02-01)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012-01-01)

Inflammatory Bowel Disease
Published: (2012)

The Clinical Features of Inflammatory Bowel Disease in Patients with Obesity
by: Seong Kyun Kim, et al.
Published: (2021-01-01)

Inflammatory bowel disease: Clinical screening and transition of care
by: Badr Al-Bawardy
Published: (2017-01-01)

Dysplasia in Inflammatory Bowel Diseases: Definition and Clinical Impact
by: Karel Geboes, et al.
Published: (1999-01-01)

Clinical Implication of Sarcopenia in Patients with Inflammatory Bowel Disease
by: Seong-Eun Kim
Published: (2018-06-01)

Clinical aspects and treatments for pediatric inflammatory bowel diseases
by: Jin Soo Moon
Published: (2019-01-01)